| AF | activator factor |
| cAMP | cyclic adenosine monophosphate |
| E2 | 17β-estradiol |
| eNOS | endothelial nitric oxide synthase |
| ERE | estrogen response element |
| ER | estrogen receptor |
| FAK | focal adhesion kinase |
| G-1 | (±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone |
| GPER1 | G-protein-coupled ER |
| HUVEC | human umbilical vein endothelial cells |
| IL | interleukin |
| IFNγ | interferon-γ |
| LBD | Ligand-Binding Domain |
| LPS | lipopolysaccharide |
| MAPK | mitogen-activated protein kinase |
| MCP-1 | monocyte chemoattractant protein-1 |
| NF-κB | nuclear factor kappa-light-chain-enhancer of activated B cells |
| NO | nitric oxide |
| PFKFB3 | phosphofructokinase-2/fructose-2,6-bisphosphatase-3 |
| PI3K | phosphatidylinositol-3-kinases |
| TNF-α | tumor necrosis factor α |
| VEGF | vascular endothelial growth factor |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.